Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statement of Stockholders' Equity (Deficit) (Unaudited)

v3.8.0.1
Consolidated Statement of Stockholders' Equity (Deficit) (Unaudited) - 9 months ended Sep. 30, 2017 - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Noncontrolling Interest [Member]
Total
Balance (in shares) at Dec. 31, 2016 155,762,729          
Balance at Dec. 31, 2016 $ 155,763 $ 326,564,148 $ (394,855,034)   $ 468,910 $ (67,666,213)
Issued stock in payment of Board retainers (in shares) 16,406          
Issued stock in payment of Board retainers $ 17 10,483       10,500
Issued stock in payment of employee bonuses (in shares) 710,353          
Issued stock in payment of employee bonuses $ 710 368,632       369,342
Issued stock upon exercise of warrants (in shares) 5,411,850          
Issued stock upon exercise of warrants $ 5,412 48,707       54,119
Issued warrants in connection with Asset Sale   3,337,187       3,337,187
Issued warrants for extension of license agreement   333,719       $ 333,719
Issued stock to 401(k) plan (in shares) 105,308         105,308
Issued stock to 401(k) plan $ 105 53,602       $ 53,707
Issued restricted stock (in shares) 200,000          
Issued restricted stock $ 200         200
Stock compensation expense   319,807       319,807
Net income     79,004,198   (192) 79,004,006
Unrealized loss on available-for-sale securities       $ (1,200)   (1,200)
Total comprehensive income           79,002,806
Reclassification of funds invested (see Note 8)         200,000 200,000
Balance (in shares) at Sep. 30, 2017 162,206,646          
Balance at Sep. 30, 2017 $ 162,207 $ 331,036,285 $ (315,850,836) $ (1,200) $ 668,718 $ 16,015,174